← Leaderboards
Michael Jay Holtzman
Washington University
$55,932,256
Attributed
$57,569,315
Total exposure
24
Grants
19
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $9.5M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$102,732,970 · 28
By mechanism
P50$31,008,875 · 6
U19$22,848,531 · 5
T32$15,187,279 · 1
R01$13,239,068 · 7
R35$6,589,100 · 1
UH3$4,691,452 · 1
Top collaborators
- Barak A Cohen5 shared
- Francis Sessions Cole5 shared
- Steven Brody2 shared
- Janet S Lee2 shared
Most similar at Washington University
Same institution · by research overlap
- Avraham Beigelman$2,521,583
- Jennifer Alexander-Brett$4,133,766
- William C Parks$19,504,252
- Michael J Walter$5,079,903
- Leonard B Bacharier$9,616,060
Others in their field
Top investigators on “Base”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$613,567,095
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$521,411,998
- Leonard Freedman · Leidos Biomedical Research, Inc.$515,995,429
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$507,042,060
Research focus
BaseEpithelial CellsAsthmaCellsLungMouse ModelVirus DiseasesViralInfectionSignal TransductionProductionProgramsMolecularChronicPathway InteractionsMucous Body SubstanceImmune ResponseEpithelialLeadRespiratory VirusSignal PathwayPreventVirusImmune
Grant awards (144)
Defining and Controlling Airway Disease$945,000
R35 · FY2025 · HL · contact PI
Principles in Pulmonary Research$258,367
T32 · FY2025 · HL · contact PI
Defining and Controlling Airway Disease$926,100
R35 · FY2024 · HL · contact PI
Principles in Pulmonary Research$909,552
T32 · FY2024 · HL · contact PI
Defining and Controlling Airway Disease$945,000
R35 · FY2023 · HL · contact PI
Defining and Controlling Airway Disease$945,000
R35 · FY2022 · HL · contact PI
Principles in Pulmonary Research$316,995
T32 · FY2022 · HL · contact PI
Defining and Controlling Airway Disease$945,000
R35 · FY2021 · HL · contact PI
Principles in Pulmonary Research$645,358
T32 · FY2021 · HL · contact PI
PARP9-DTX3L Control Of Viral Infection and Airway Disease$608,777
R01 · FY2021 · AI · contact PI
Defining and Controlling Airway Disease$944,000
R35 · FY2020 · HL · contact PI
Principles in Pulmonary Research$887,878
T32 · FY2020 · HL · contact PI
PARP9-DTX3L Control Of Viral Infection and Airway Disease$608,777
R01 · FY2020 · AI · contact PI
Defining and Controlling Airway Disease$939,000
R35 · FY2019 · HL · contact PI
Principles in Pulmonary Research$857,186
T32 · FY2019 · HL · contact PI
PARP9-DTX3L Control Of Viral Infection and Airway Disease$608,777
R01 · FY2019 · AI · contact PI
Preclinical Development of an Anti-Mucus Drug$1,662,288
UH3 · FY2018 · HL · contact PI
Principles in Pulmonary Research$835,085
T32 · FY2018 · HL · contact PI
PARP9-DTX3L Control Of Viral Infection and Airway Disease$608,777
R01 · FY2018 · AI · contact PI
TREM2 AND AIRWAY DISEASE$440,127
R01 · FY2018 · HL · contact PI
Preclinical Development of an Anti-Mucus Drug$1,504,184
UH3 · FY2017 · HL · contact PI
PARP9-DTX3L Control Of Viral Infection and Airway Disease$608,777
R01 · FY2017 · AI · contact PI
IL-33 AND EXCESS MUCUS PRODUCTION$464,792
R01 · FY2017 · HL · contact PI
TREM2 AND AIRWAY DISEASE$449,363
R01 · FY2017 · HL · contact PI
INTERFERON SIGNAL ENHANCERS AS ANTIVIRAL THERAPEUTICS$440,934
R01 · FY2017 · AI · contact PI
Principles in Pulmonary Research$396,204
T32 · FY2017 · HL · contact PI
Omics of Inflammatory Airway Diseases$319,116
K12 · FY2017 · HL
Principles in Pulmonary Research$5,888
T32 · FY2017 · HL · contact PI
Preclinical Development of an Anti-Mucus Drug$1,524,980
UH3 · FY2016 · HL · contact PI
Principles in Pulmonary Research$734,461
T32 · FY2016 · HL · contact PI
IL-33 AND EXCESS MUCUS PRODUCTION$470,621
R01 · FY2016 · HL · contact PI
TREM2 AND AIRWAY DISEASE$458,307
R01 · FY2016 · HL · contact PI
INTERFERON SIGNAL ENHANCERS AS ANTIVIRAL THERAPEUTICS$440,934
R01 · FY2016 · AI · contact PI
Omics of Inflammatory Airway Diseases$320,031
K12 · FY2016 · HL
Epithelial Barrier Programs in Asthma and Allergic Disease$249,999
U19 · FY2016 · AI · contact PI
Airway epithelial defense and interferon$249,999
U19 · FY2016 · AI · contact PI
Epithelial Barrier Programs in Asthma and Allergic Disease$1,567,435
U19 · FY2015 · AI · contact PI
Preclinical Development of an Anti-Mucus Drug$1,485,085
UH2 · FY2015 · HL · contact PI
Principles in Pulmonary Research$616,209
T32 · FY2015 · HL · contact PI
IL-33 AND EXCESS MUCUS PRODUCTION$469,191
R01 · FY2015 · HL · contact PI
INTERFERON SIGNAL ENHANCERS AS ANTIVIRAL THERAPEUTICS$440,934
R01 · FY2015 · AI · contact PI
Airway epithelial defense and interferon$340,032
U19 · FY2015 · AI · contact PI
Omics of Inflammatory Airway Diseases$267,253
K12 · FY2015 · HL
Administrative Core$103,742
U19 · FY2015 · AI · contact PI
Epithelial Barrier Programs in Asthma and Allergic Disease$1,567,435
U19 · FY2014 · AI · contact PI
Preclinical Development of an Anti-Mucus Drug$1,513,398
UH2 · FY2014 · HL · contact PI
Principles in Pulmonary Research$705,711
T32 · FY2014 · HL · contact PI
IL-33 AND EXCESS MUCUS PRODUCTION$481,924
R01 · FY2014 · HL · contact PI
INTERFERON SIGNAL ENHANCERS AS ANTIVIRAL THERAPEUTICS$440,925
R01 · FY2014 · AI · contact PI
Airway epithelial defense and interferon$396,238
U19 · FY2014 · AI · contact PI
Omics of Inflammatory Airway Diseases$268,136
K12 · FY2014 · HL
Administrative Core$120,289
U19 · FY2014 · AI · contact PI
Epithelial Barrier Programs in Asthma and Allergic Disease$1,473,389
U19 · FY2013 · AI · contact PI
Principles in Pulmonary Research$662,327
T32 · FY2013 · HL · contact PI
Airway epithelial defense and interferon$372,544
U19 · FY2013 · AI · contact PI
Stat 1 modification for antiviral defense$362,414
U54 · FY2013 · AI · contact PI
Omics of Inflammatory Airway Diseases$113,134
K12 · FY2013 · HL
Administrative Core$113,071
U19 · FY2013 · AI · contact PI
Mechanisms in the Remodeling of Lung Structure$1,661,181
P01 · FY2012 · HL · contact PI
Epithelial Barrier Programs in Asthma and Allergic Disease$1,567,435
U19 · FY2012 · AI · contact PI
Principles in Pulmonary Research$486,236
T32 · FY2012 · HL · contact PI
Target Validation and Assay Development for Anti-Mucus Therapy$456,000
P50 · FY2012 · HL · contact PI
Airway epithelial defense and interferon$397,009
U19 · FY2012 · AI · contact PI
Stat 1 modification for antiviral defense$372,586
U54 · FY2012 · AI · contact PI
New Immune Pathways for Epithelial Remodeling$237,311
P01 · FY2012 · HL · contact PI
Administrative Core$120,495
U19 · FY2012 · AI · contact PI
Alveolar and Airway Mechanisms for COPD$2,803,266
P50 · FY2011 · HL · contact PI
Epithelial Barrier Programs in Asthma and Allergic Disease$1,571,170
U19 · FY2011 · AI · contact PI
Airway Determinants: Innate Immune Signaling$567,503
P50 · FY2011 · HL · contact PI
Principles in Pulmonary Research$533,938
T32 · FY2011 · HL · contact PI
Target Validation and Assay Development for Anti-Mucus Therapy$456,000
P50 · FY2011 · HL · contact PI
BASIS OF CHRONIC MUCOUS CELL METAPLASIA$396,291
R01 · FY2011 · HL · contact PI
Stat 1 modification for antiviral defense$383,251
U54 · FY2011 · AI · contact PI
Airway epithelial defense and interferon$336,612
U19 · FY2011 · AI · contact PI
New Immune Pathways for Epithelial Remodeling$240,424
P01 · FY2011 · HL · contact PI
Administrative$191,237
P50 · FY2011 · HL · contact PI
Administrative Core$158,231
U19 · FY2011 · AI · contact PI
Alveolar and Airway Mechanisms for COPD$2,802,957
P50 · FY2010 · HL · contact PI
Innate and Adaptive Immune Signaling in Asthma$1,511,652
U19 · FY2010 · AI · contact PI
Principles in Pulmonary Research$674,076
T32 · FY2010 · HL · contact PI
Airway Determinants: Innate Immune Signaling$567,290
P50 · FY2010 · HL · contact PI
Stat 1 modification for antiviral defense$400,534
U54 · FY2010 · AI · contact PI
BASIS OF CHRONIC MUCOUS CELL METAPLASIA$400,295
R01 · FY2010 · HL · contact PI
Stat1 Signaling and Airway Epithelial Cells$384,282
U19 · FY2010 · AI · contact PI
New Immune Pathways for Epithelial Remodeling$249,882
P01 · FY2010 · HL · contact PI
Administrative$191,237
P50 · FY2010 · HL · contact PI
Administrative Core$105,738
U19 · FY2010 · AI · contact PI
Alveolar and Airway Mechanisms for COPD$2,802,168
P50 · FY2009 · HL · contact PI
Innate and Adaptive Immune Signaling in Asthma$1,976,256
U19 · FY2009 · AI · contact PI
Innate and Adaptive Immune Signaling in Asthma$1,499,203
U19 · FY2009 · AI · contact PI
Principles in Pulmonary Research$669,216
T32 · FY2009 · HL · contact PI
Airway Determinants: Innate Immune Signaling$567,083
P50 · FY2009 · HL · contact PI
Innate and Adaptive Immune Signaling in Asthma$492,583
U19 · FY2009 · AI · contact PI
BASIS OF CHRONIC MUCOUS CELL METAPLASIA$398,653
R01 · FY2009 · HL · contact PI
Stat 1 modification for antiviral defense$382,022
U54 · FY2009 · AI · contact PI
Stat1 Signaling and Airway Epithelial Cells$378,344
U19 · FY2009 · AI · contact PI
Administrative$191,237
P50 · FY2009 · HL · contact PI
Administrative Core$104,057
U19 · FY2009 · AI · contact PI
Alveolar and Airway Mechanisms for COPD$2,746,200
P50 · FY2008 · HL · contact PI
Innate and Adaptive Immune Signaling in Asthma$1,462,270
U19 · FY2008 · AI · contact PI
Principles in Pulmonary Research$664,369
T32 · FY2008 · HL · contact PI
Airway Determinants: Innate Immune Signaling$566,882
P50 · FY2008 · HL · contact PI
BASIS OF CHRONIC MUCOUS CELL METAPLASIA$387,443
R01 · FY2008 · HL · contact PI
Stat1 Signaling and Airway Epithelial Cells$369,121
U19 · FY2008 · AI · contact PI
Administrative$191,237
P50 · FY2008 · HL · contact PI
Administrative Core$101,483
U19 · FY2008 · AI · contact PI
Alveolar and Airway Mechanisms for COPD$2,844,679
P50 · FY2007 · HL · contact PI
Innate and Adaptive Immune Signaling in Asthma$1,454,049
U19 · FY2007 · AI · contact PI
Principles in Pulmonary Research$647,521
T32 · FY2007 · HL · contact PI
Airway Determinants: Innate Immune Signaling$567,608
P50 · FY2007 · HL · contact PI
Basis of Airway Epithelial Cell Survival$367,907
P01 · FY2007 · HL · contact PI
Stat1 Signaling and Airway Epithelial Cells$325,785
U19 · FY2007 · AI · contact PI
Administrative$191,552
P50 · FY2007 · HL · contact PI
Administrative Core$67,452
U19 · FY2007 · AI · contact PI
Innate and Adaptive Immune Signaling in Asthma$1,460,462
U19 · FY2006 · AI · contact PI
Principles in Pulmonary Research$452,374
T32 · FY2006 · HL · contact PI
Basis of Long-Term Virus-Induced Goblet Cell Hyperplasia$373,511
R01 · FY2006 · HL · contact PI
Stat1 Signaling and Airway Epithelial Cells$315,329
U19 · FY2006 · AI · contact PI
Administrative Core$135,340
U19 · FY2006 · AI · contact PI
SCOR: Mechanisms of Airway Inflammation and Remodeling$2,065,287
P50 · FY2005 · HL
Principles in Pulmonary Research$446,249
T32 · FY2005 · HL
Basis of Long-Term Virus-Induced Goblet Cell Hyperplasia$382,500
R01 · FY2005 · HL
STAT1 DEPENDENT GENE REGULATION$271,250
P50 · FY2005 · HL
SCOR: Mechanisms of Airway Inflammation and Remodeling$2,113,267
P50 · FY2004 · HL
Principles in Pulmonary Research$656,565
T32 · FY2004 · HL
Basis of Long-Term Virus-Induced Goblet Cell Hyperplasia$382,500
R01 · FY2004 · HL
SCOR: Mechanisms of Airway Inflammation and Remodeling$2,059,209
P50 · FY2003 · HL
Principles in Pulmonary Research$649,139
T32 · FY2003 · HL
Basis of Long-Term Virus-Induced Goblet Cell Hyperplasia$382,500
R01 · FY2003 · HL
Basis of Airway Epithelial Cell Survival$225,000
P01 · FY2003 · HL
SCOR: Mechanisms of Airway Inflammation and Remodeling$2,006,194
P50 · FY2002 · HL
PRINCIPLES IN PULMONARY RESEARCH$483,424
T32 · FY2002 · HL
VIRUS INDUCED GENE EXPRESSION IN AIRWAY EPITHELIAL CELLS$351,000
R01 · FY2002 · HL
VIRUS-INDUCIBLE REMODELING OF AIRWAY EPITHELIUM$346,500
R01 · FY2002 · HL
STAT1 DEPENDENT GENE REGULATION$172,411
P50 · FY2002 · HL
SCOR: Mechanisms of Airway Inflammation and Remodeling$1,555,180
P50 · FY2001 · HL
PRINCIPLES IN PULMONARY RESEARCH$533,093
T32 · FY2001 · HL
VIRUS INDUCED GENE EXPRESSION IN AIRWAY EPITHELIAL CELLS$351,000
R01 · FY2001 · HL
VIRUS-INDUCIBLE REMODELING OF AIRWAY EPITHELIUM$346,500
R01 · FY2001 · HL
MECHANISMS OF AIRWAY INFLAMMATION$1,850,729
P50 · FY2000 · HL
PRINCIPLES IN PULMONARY RESEARCH$459,858
T32 · FY2000 · HL
VIRUS INDUCED GENE EXPRESSION IN AIRWAY EPITHELIAL CELLS$351,000
R01 · FY2000 · HL
VIRUS-INDUCIBLE REMODELING OF AIRWAY EPITHELIUM$347,438
R01 · FY2000 · HL
STAT1 DEPENDENT GENE REGULATION$211,212
P50 · FY2000 · HL